Skip to Content

Ciprofloxacin / dexamethasone otic Pregnancy and Breastfeeding Warnings

Ciprofloxacin / dexamethasone otic is also known as: Ciprodex

Ciprofloxacin / dexamethasone otic Pregnancy Warnings

Animal reproduction studies of ciprofloxacin have revealed evidence of abortion at doses that produced maternal gastrointestinal disturbances and weight loss. Corticosteroids have revealed evidence of teratogenicity and changes to the testes, epididymis, sperm duct, prostate, seminal vesicle, Cowper's and accessory glands after dermal administration. There are no controlled data for either drug in human pregnancy. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus. US FDA pregnancy category: C

See references

Ciprofloxacin / dexamethasone otic Breastfeeding Warnings

Use is not recommended and a decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Unknown Comment: The effects in the nursing infant are unknown.

Ciprofloxacin and corticosteroids, such as dexamethasone, are excreted into breastmilk when administered orally. Excreted dexamethasone may result in growth suppression, interference with endogenous corticosteroid production, and/or other effects in the infant.

See references

References for pregnancy information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  2. "Product Information. Ciprodex (ciprofloxacin-dexamethasone otic)." Alcon Laboratories Inc, Fort Worth, TX.

References for breastfeeding information

  1. "Product Information. Ciprodex (ciprofloxacin-dexamethasone otic)." Alcon Laboratories Inc, Fort Worth, TX.
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  3. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.